NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

Although the verification is very good to see, my skepticism still lies within total resection survival. Are we really to believe eliminating the tumor means so little in terms of additional OS? If that's the case, I'm wondering about the outcomes of the study trial and if they saw the same survival figures?


I disagree with the reports 60 months 5.7% SOC OS figure. I believe with TTF and other experimental treatments these days that figure is closer to 10%.


Idunno, don't get ahead of yourself. Legacy shareholders are still in the dumpster. The stock has lost ground since the run two years ago. I actually feel bad for all of you who so boldly held on. You deserved a stock move where new investors were buying at a real premium, but it never materialized. Boggles the mind one can wait five years for the "Big event" and see so little action. I guess that's what a billion and a half outstanding can do in a lousy biotech market. But not even a buyout offer or a partnership announcement to accompany this journal report seems like a real slap.

And, I still don't see anyone here talking about proper transparency on the CDMO, better governance in terms of an independent CFO and Chair, or even demanding quarterly calls.